+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Caspofungin Market by Indication (Candidiasis, Thrush), Application (Hospitals, Outpatient Care Centers, Specialty Clinics), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968352
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Caspofungin Market grew from USD 616.96 million in 2023 to USD 643.80 million in 2024. It is expected to continue growing at a CAGR of 4.38%, reaching USD 833.07 million by 2030.

This inhibitory action disrupts the integrity of the cell wall, making it difficult for fungal cells to maintain their structure and ultimately leading to their death. Caspofungin is primarily used in the treatment of serious fungal infections, often those caused by the Candida or Aspergillus species. Caspofungin is usually administered via injection and is considered a critical option when other antifungal treatments are ineffective and cannot be tolerated. The rising global prevalence of fungal infections escalates the demand for effective antifungal therapies. Initiatives to improve healthcare infrastructure and accessibility to advanced therapeutics propel the adoption of effective treatments such as Caspofungin. However, stringent regulatory requirements for drug approval can delay the introduction of improved formulations or new applications of Caspofungin. Furthermore, improvements in diagnostic techniques for the rapid identification of fungal infections bolster the use of targeted therapies, including Caspofungin. Developing new formulations of Caspofungin with better patient outcomes, fewer side effects, and easier administration, such as oral dosing, would increase its market footprint.

Regional Insights

The American region represents a significant market for caspofungin, primarily due to the high prevalence of invasive fungal infections and a robust healthcare infrastructure capable of supporting advanced antifungal therapies. Consumer need in the Americas largely stems from the immunocompromised patient groups, such as those undergoing cancer treatments or living with HIV/AIDS, where fungal infections are a serious concern. Investment continues to grow in research and development, especially focusing on combinatorial therapies using caspofungin to tackle multi-drug resistant fungal strains. Countries within the EU show a high awareness and adoption rate of newer antifungal therapies, including caspofungin. Research initiatives often involve multicentric studies across several EU countries, evaluating the drug's use in various demographics and alongside new therapeutic agents. Middle Eastern countries with well-developed healthcare systems have access to drugs, including caspofungin. APAC has a rapidly growing pharmaceutical market, and the demand for antifungal treatments, including caspofungin, has been increasing due to greater healthcare spending and awareness of fungal infections. The APAC countries focus on improving healthcare infrastructure and domestic pharmaceutical capabilities, which bodes well for the diffusion of advanced treatments.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Caspofungin Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising global prevalence of fungal infections
  • Favorable regulatory approvals and support new formulations and drug application
  • Technological advances in pharmaceutical technologies to improve the therapeutic outcomes

Market Restraints

  • Issues related to product recall and safety concerns

Market Opportunities

  • Investment in improving manufacturing techniques for caspofungin to reduce production costs and enhance product quality
  • Implementing awareness campaigns about the risks and prevention of fungal infections

Market Challenges

  • Counterfeit products and shortage of skilled workforce

Market Segmentation Analysis

  • Indication: Growing prevalence of candidiasis accelerating demand for caspofungin
  • Distribution Channel: Increasing importance of hospital pharmacies due to the necessity of administering the drug under medical supervision

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Caspofungin Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Caspofungin Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

UK Approval of REZZAYO for Invasive Candidiasis Augments Treatment Portfolio

Cidara Therapeutics, Inc., in association with Mundipharma, announced the approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of REZZAYO (rezafungin acetate) for the cure of invasive candidiasis in adults. This marks a significant development as REZZAYO is the first new therapy introduced in 15 years for this life-threatening infection, which boasts high mortality rates of up to 40% among severely ill individuals. Efficacy and safety endorsements for REZZAYO stem from its promising outcomes in the ReSTORE Phase III trial, where it showed non-inferiority to the daily-dosed standard care, caspofungin, offering a less frequent, weekly dosage regimen.

Innovative Antifungal Treatment Rezafungin Gains FDA Approval

Rezafungin (REZZAYOTM), approved by the FDA, is a breakthrough therapy for patients suffering from candidemia and invasive candidiasis, marking the first significant advancement in treatments for these conditions in more than a decade. The approval is based on results from the ReSTORE Phase 3 clinical trial, where Thompson played a key role. Conducted across 66 tertiary care centers in 15 countries, this randomized, double-blind trial included adult participants who were administered either rezafungin or the daily treatment of caspofungin, which has been the standard care. The study's results were closely matched, with approximately the same number of patients from both the rezafungin (59%) and caspofungin (61%) groups showing a cure at day 14.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Caspofungin Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Caspofungin Market, highlighting leading vendors and their innovative profiles. These include Alkem Laboratories Limited, Alvogen Inc., Avalon Pharma Pvt. Ltd, Cidara Therapeutics, Inc., Cipla Inc., Fresenius SE & Co. KGaA, Gland Pharma Limited, Glenmark Pharmaceuticals Limited, Gufic Biosciences Ltd., Intas Pharmaceuticals Limited, Juno Pharmaceuticals Corporation, McKesson Corporation, Merck & Co., Inc., Midas Pharma GmbH, Mylan N.V., Stanex Drugs & Chemical Pvt. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Xellia Pharmaceuticals ApS by Novo Holdings A/S, and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Caspofungin Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication

  • Candidiasis
  • Thrush

Application

  • Hospitals
  • Outpatient Care Centers
  • Specialty Clinics

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising global prevalence of fungal infections
5.1.1.2. Favorable regulatory approvals and support new formulations and drug application
5.1.1.3. Technological advances in pharmaceutical technologies to improve the therapeutic outcomes
5.1.2. Restraints
5.1.2.1. Issues related to product recall and safety concerns
5.1.3. Opportunities
5.1.3.1. Investment in improving manufacturing techniques for caspofungin to reduce production costs and enhance product quality
5.1.3.2. Implementing awareness campaigns about the risks and prevention of fungal infections
5.1.4. Challenges
5.1.4.1. Counterfeit products and shortage of skilled workforce
5.2. Market Segmentation Analysis
5.2.1. Indication: Growing prevalence of candidiasis accelerating demand for caspofungin
5.2.2. Distribution Channel: Increasing importance of hospital pharmacies due to the necessity of administering the drug under medical supervision
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Caspofungin Market, by Indication
6.1. Introduction
6.2. Candidiasis
6.3. Thrush
7. Caspofungin Market, by Application
7.1. Introduction
7.2. Hospitals
7.3. Outpatient Care Centers
7.4. Specialty Clinics
8. Caspofungin Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Retail Pharmacies
9. Americas Caspofungin Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Caspofungin Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Caspofungin Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. UK Approval of REZZAYO for Invasive Candidiasis Augments Treatment Portfolio
12.3.2. Innovative Antifungal Treatment Rezafungin Gains FDA Approval
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. CASPOFUNGIN MARKET RESEARCH PROCESS
FIGURE 2. CASPOFUNGIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CASPOFUNGIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CASPOFUNGIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CASPOFUNGIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CASPOFUNGIN MARKET DYNAMICS
FIGURE 7. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CASPOFUNGIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. CASPOFUNGIN MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CASPOFUNGIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CASPOFUNGIN MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CASPOFUNGIN MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CASPOFUNGIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CASPOFUNGIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CASPOFUNGIN MARKET SIZE, BY CANDIDIASIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CASPOFUNGIN MARKET SIZE, BY CANDIDIASIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CASPOFUNGIN MARKET SIZE, BY THRUSH, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CASPOFUNGIN MARKET SIZE, BY THRUSH, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CASPOFUNGIN MARKET SIZE, BY OUTPATIENT CARE CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CASPOFUNGIN MARKET SIZE, BY OUTPATIENT CARE CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CASPOFUNGIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CASPOFUNGIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 35. ARGENTINA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 36. ARGENTINA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 41. BRAZIL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 42. BRAZIL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 47. CANADA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 48. CANADA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 49. CANADA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. CANADA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. CANADA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 52. CANADA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 53. MEXICO CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 54. MEXICO CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 55. MEXICO CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. MEXICO CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. MEXICO CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 58. MEXICO CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 59. UNITED STATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 60. UNITED STATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 68. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 76. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 81. CHINA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 82. CHINA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 83. CHINA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. CHINA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. CHINA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 86. CHINA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 87. INDIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 88. INDIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 89. INDIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. INDIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. INDIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 92. INDIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 93. INDONESIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 94. INDONESIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 99. JAPAN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. JAPAN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. JAPAN CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. JAPAN CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. JAPAN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 104. JAPAN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 105. MALAYSIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 106. MALAYSIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 111. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 112. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 117. SINGAPORE CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 118. SINGAPORE CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 123. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 124. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 129. TAIWAN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 130. TAIWAN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 135. THAILAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 136. THAILAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 137. THAILAND CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. THAILAND CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. THAILAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 140. THAILAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 141. VIETNAM CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 142. VIETNAM CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 155. DENMARK CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 156. DENMARK CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 157. DENMARK CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. DENMARK CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. DENMARK CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 160. DENMARK CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 161. EGYPT CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 162. EGYPT CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 163. EGYPT CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. EGYPT CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. EGYPT CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. EGYPT CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. FINLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 168. FINLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 169. FINLAND CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. FINLAND CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. FINLAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 172. FINLAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 173. FRANCE CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. FRANCE CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. FRANCE CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. FRANCE CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FRANCE CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 178. FRANCE CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 179. GERMANY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 180. GERMANY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 181. GERMANY CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. GERMANY CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. GERMANY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 184. GERMANY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 185. ISRAEL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. ISRAEL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 191. ITALY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 192. ITALY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 193. ITALY CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. ITALY CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ITALY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. ITALY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 198. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 203. NIGERIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 204. NIGERIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 209. NORWAY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 210. NORWAY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 211. NORWAY CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NORWAY CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NORWAY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 214. NORWAY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 215. POLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 216. POLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 217. POLAND CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. POLAND CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. POLAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 220. POLAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 221. QATAR CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 222. QATAR CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 223. QATAR CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. QATAR CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. QATAR CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 226. QATAR CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 227. RUSSIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. RUSSIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 240. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 245. SPAIN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 246. SPAIN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 247. SPAIN CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SPAIN CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SPAIN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 250. SPAIN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 251. SWEDEN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 252. SWEDEN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 257. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 258. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 263. TURKEY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 264. TURKEY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 265. TURKEY CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. TURKEY CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. TURKEY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 268. TURKEY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 281. CASPOFUNGIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 282. CASPOFUNGIN MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alkem Laboratories Limited
  • Alvogen Inc.
  • Avalon Pharma Pvt. Ltd
  • Cidara Therapeutics, Inc.
  • Cipla Inc.
  • Fresenius SE & Co. KGaA
  • Gland Pharma Limited
  • Glenmark Pharmaceuticals Limited
  • Gufic Biosciences Ltd.
  • Intas Pharmaceuticals Limited
  • Juno Pharmaceuticals Corporation
  • McKesson Corporation
  • Merck & Co., Inc.
  • Midas Pharma GmbH
  • Mylan N.V.
  • Stanex Drugs & Chemical Pvt. Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Xellia Pharmaceuticals ApS by Novo Holdings A/S
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 643.8 Million
Forecasted Market Value ( USD ) by 2030 $ 833.07 Million
Compound Annual Growth Rate4.3%
Regions CoveredGlobal

Related Topics

Related Reports

Global Caspofungin Market - Product Image

Global Caspofungin Market

  • Report
  • 200 Pages
  • Global
From
Global Antifungal Drugs Market by Infection Type (Superficial Fungal Infection, Systemic Fungal infection), Type (Allylamines, Azoles, Echinocandins), Form, Therapeutic Indications - Forecast 2024-2030 - Product Image

Global Antifungal Drugs Market by Infection Type (Superficial Fungal Infection, Systemic Fungal infection), Type (Allylamines, Azoles, Echinocandins), Form, Therapeutic Indications - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Anti Fungal Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Anti Fungal Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Antifungal Drugs Market Report by Drug Class, Indication, and Region 2024-2032 - Product Image

Antifungal Drugs Market Report by Drug Class, Indication, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Candidemia - Pipeline Insight, 2024 - Product Image

Candidemia - Pipeline Insight, 2024

  • Clinical Trials
  • 40 Pages
  • Global
From

About the Market

Caspofungin is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida species. It is a member of the echinocandin class of antifungal drugs, which are used to treat serious fungal infections in immunocompromised patients. Caspofungin is typically used in combination with other antifungal drugs, such as amphotericin B or fluconazole, to treat infections that are resistant to other antifungal agents. It is also used to treat infections caused by Aspergillus species, which are often difficult to treat. Caspofungin is an important drug in the treatment of infectious diseases, as it is effective against a wide range of fungal infections. It is also well tolerated, with few side effects. As such, it is an important part of the infectious diseases drugs market. Companies in the caspofungin market include Merck & Co., Pfizer, Astellas Pharma, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.